ClinicalTrials.Veeva

Menu

Comparison of Insulin Pump and MDI for Pregestational Diabetes During Pregnancy

University of British Columbia logo

University of British Columbia

Status

Terminated

Conditions

Type 1 Diabetes
Type 2 Diabetes
Pregnancy

Treatments

Device: insulin pump
Other: multiple daily insulin injection

Study type

Interventional

Funder types

Other

Identifiers

NCT02064023
H12-02375

Details and patient eligibility

About

This study is investigating whether insulin treatment with the insulin pump or with multiple daily injections (MDI) gives better outcomes for mother and baby in pregnant women with pregestational diabetes. Participants will be randomized to use either the insulin pump or MDI.

Full description

Primary outcome is a composite of Cesarian section, instrumental delivery, maternal hypertension, LGA infant, neonatal hypoglycemia or SCN admission.

Enrollment

2 patients

Sex

Female

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • subjects are attending the Diabetes Pregnancy Clinic at participating hospitals
  • have had type 1 or type 2 diabetes for at least one year
  • are in the first trimester or are actively attempting pregnancy
  • have a singleton pregnancy
  • are receiving intensive insulin therapy
  • are judged by clinic staff to be capable of using an insulin pump
  • are age 19 or older
  • are willing to adhere to the study protocol including monitoring blood glucose levels
  • are willing to take folic acid before pregnancy and during the first trimester
  • are willing to discontinue any medication contraindicated in pregnancy prior to conception
  • weigh less than 100 kg (220 lb) prior to becoming pregnant
  • use less than 100 units of insulin per day

Exclusion criteria

  • current or previous use of an insulin pump
  • use of fertility treatments
  • have a multiple pregnancy
  • have had children born with major birth defects
  • have experienced stillbirth or multiple early pregnancy losses
  • have significant diabetes complications or a serious medical issue

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

2 participants in 2 patient groups

insulin pump
Experimental group
Description:
subjects will use an insulin pump for the duration of the pregnancy. The intervention is that they will control their diabetes using an insulin pump
Treatment:
Device: insulin pump
Multiple Daily Insulin injections
Active Comparator group
Description:
subjects will continue their usual insulin treatment with multiple daily injections of sc insulin
Treatment:
Other: multiple daily insulin injection

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems